Nj State Employees Deferred Compensation Plan Xenon Pharmaceuticals Inc. Transaction History
Nj State Employees Deferred Compensation Plan
- $789 Million
- Q2 2024
A detailed history of Nj State Employees Deferred Compensation Plan transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Nj State Employees Deferred Compensation Plan holds 25,000 shares of XENE stock, worth $1.04 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
25,000
Previous 25,000
-0.0%
Holding current value
$1.04 Million
Previous $1.08 Million
9.48%
% of portfolio
0.12%
Previous 0.14%
Shares
3 transactions
Others Institutions Holding XENE
# of Institutions
222Shares Held
69.8MCall Options Held
59.7KPut Options Held
60.7K-
Avoro Capital Advisors LLC New York, NY5.67MShares$237 Million3.02% of portfolio
-
Driehaus Capital Management LLC Chicago, IL4.42MShares$185 Million1.86% of portfolio
-
Wellington Management Group LLP Boston, MA3.83MShares$160 Million0.03% of portfolio
-
Commodore Capital LP New York, NY2.75MShares$115 Million9.63% of portfolio
-
Capital World Investors Los Angeles, CA2.68MShares$112 Million0.02% of portfolio
About Xenon Pharmaceuticals Inc.
- Ticker XENE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,263,500
- Market Cap $2.6B
- Description
- Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...